<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Introduction </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001992'>Organic acidurias</z:hpo> are a group of hereditary <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic disorders</z:e> characterized by an increase in excretion of organic acids in urine </plain></SENT>
<SENT sid="2" pm="."><plain>L-2 hydroxyglutaric <z:hpo ids='HP_0012072'>aciduria</z:hpo> is a <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> with <z:hpo ids='HP_0003587'>insidious onset</z:hpo> after infancy, which is likely inherited in an <z:hpo ids='HP_0000007'>autosomal recessive</z:hpo> mode, characterized by <z:hpo ids='HP_0006887'>mental retardation, progressive</z:hpo> <z:hpo ids='HP_0001251'>ataxia</z:hpo>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, <z:hpo ids='HP_0000256'>macrocephaly</z:hpo>, pyramidalism and <z:hpo ids='HP_0002071'>extrapyramidal symptoms</z:hpo> in variable combinations, with subcortical <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> and <z:hpo ids='HP_0002059'>cerebral atrophy</z:hpo> in neuroimaging studies </plain></SENT>
<SENT sid="3" pm="."><plain>Biochemical diagnosis was based on the detection of high levels of L-2 hydroxyglutaric acid in body fluids </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical case </plain></SENT>
<SENT sid="5" pm="."><plain>We present the case of a 42 year old male patient with psychomotor <z:e sem="disease" ids="C0424605" disease_type="Mental or Behavioral Dysfunction" abbrv="">development delay</z:e>, generalized tonic <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> crisis, and <z:hpo ids='HP_0001251'>ataxia</z:hpo> and pyramidal syndrome after the age of 18 months </plain></SENT>
<SENT sid="6" pm="."><plain>Neuroimaging study findings revealed subcortical <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Diagnosis of the disease was reached after measuring the level of L-2 hydroxyglutaric acid in body fluid (blood, urine and cerebrospinal fluid) </plain></SENT>
<SENT sid="8" pm="."><plain>This diagnosis was also confirmed in three of the patient's brothers who were affected by a non-filial <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e> by measurement of this acid level in urine </plain></SENT>
<SENT sid="9" pm="."><plain>The genetic study was performed in <z:hpo ids='HP_0000001'>all</z:hpo> the cases </plain></SENT>
<SENT sid="10" pm="."><plain>Discussion </plain></SENT>
<SENT sid="11" pm="."><plain>As with the majority of patients who reach adulthood without having been diagnosed of this disease during infancy, we believe that this disorder should be considered as a possibility in adults presenting a combination of the symptoms described and subcortical <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> in magnetic resonance imaging, regardless of whether there is a family background of it </plain></SENT>
<SENT sid="12" pm="."><plain>Thus, it should be included in the differential diagnosis of <z:hpo ids='HP_0002415'>leukodystrophy</z:hpo> in adult patients </plain></SENT>
</text></document>